Publication | Open Access
Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry
56
Citations
64
References
2022
Year
MedicineImmunologyAntiviral Drug DevelopmentAntiviral TherapyAce2 Enzymatic ActivityAntiviral DrugViral EntryPharmacologyCovid-19
| Year | Citations | |
|---|---|---|
Page 1
Page 1